{"name": "idursulfase", "category": "drug", "content": "Idursulfase (brand name Elaprase), manufactured by Takeda, is a drug used to treat Hunter syndrome (also called MPS-II). It is a purified form of iduronate-2-sulfatase, a lysosomal enzyme, and is produced by recombinant DNA technology in a human cell line. It is one of the most expensive drugs ever produced, costing US$567,412 per patient per year.   == References ==   == External links == idursulfase at the U.S. National Library of Medicine Medical Subject Headings (MeSH)"}